KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis
KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis. // Peptides. – URL: https://www.sciencedirect.com/science/article/pii/S0196978126000549?dgcid=rss_sd_all
KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis. Peptides. https://www.sciencedirect.com/science/article/pii/S0196978126000549?dgcid=rss_sd_all
“KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis.” Peptides.
@article{article5803,
title = {KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis},
journal = {Peptides},
url = {https://www.sciencedirect.com/science/article/pii/S0196978126000549?dgcid=rss_sd_all}
}